WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.
about
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.
@en
WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.
@nl
type
label
WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.
@en
WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.
@nl
prefLabel
WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.
@en
WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.
@nl
P2093
P2860
P1476
WT1 peptide vaccine in Montani ...... nrichment in myeloid leukemia.
@en
P2093
Andres M Salazar
Gregory Malnassy
Jae-Hyun Park
Margaret Green
Noreen Fulton
Noura Choudhury
Olatoyosi Odenike
Richard A Larson
Thomas F Gajewski
Wendy Stock
P2860
P2888
P356
10.1186/S40164-018-0093-X
P50
P577
2018-01-11T00:00:00Z
P6179
1100315844